Pronađeno: 1-10 / 19 radova

Autori: Molden Espen

>> Filter: Samo Article i Review

Naslov Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials (Review)
Autori Milosavljevic Filip  Molden Espen  Ingelman Sundberg Magnus  Jukic Marin M 
Info EUROPEAN NEUROPSYCHOPHARMACOLOGY, (2024), vol. 81 br. , str. 43-52
Projekat Swedish Research Council [2021-02732]; Science Fund of the Republic of Serbia [6066800]; Swedish Brain Foundation [FO2021-0314]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov What is the Current Clinical Impact of the CYP2CTG Haplotype? (Letter; Early Access)
Autori Ingelman-Sundberg Magnus  Jukic Marin M  Braten Line Skute  Kringen Marianne Kristiansen  Molden Espen 
Info CLINICAL PHARMACOLOGY & THERAPEUTICS, (2023), vol. br. , str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati:
Naslov Pharmacogenomics in treatment of depression and psychosis: an update (Review)
Autori Jukic Marin M  Milosavljevic Filip  Molden Espen  Ingelman-Sundberg Magnus 
Info TRENDS IN PHARMACOLOGICAL SCIENCES, (2022), vol. 43 br. 12, str. 1055-1069
Projekat European Research Council (ERC) Advanced Grant (AdG) [742020]; Swedish Research Council [2021-02732, 2018-05766]; Science Fund of the Republic of Serbia [6066800]; Swedish Brain Foundation [FO2021-0314]; European Union ? [94515]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Impact of NFIB and CYP1A variants on clozapine serum concentration-A retrospective naturalistic cohort study on 526 patients with known smoking habits (Article; Early Access)
Autori Lenk Hasan Cagin  Lovsletten Smith Robert  O'Connell Kevin S  Jukic Marin M  Kringen Marianne Kristiansen  Andreassen Ole A  Ingelman-Sundberg Magnus  Molden Espen 
Info CTS-CLINICAL AND TRANSLATIONAL SCIENCE, (2022), vol. br. , str. -
Projekat Swedish Research Council [2021-02732]; European Union [964874/REALMENT]; South-Eastern Norway Regional Health Authority [2020019]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Association Between CYP2D6 Metabolizer Status and Vortioxetine Exposure and Treatment Switching A Retrospective, Naturalistic Cohort Study Using Therapeutic Drug Monitoring Data From 640 Patients (Article)
Autori Frederiksen Trine  Smith Robert Lovsletten  Jukic Marin M  Molden Espen 
Info JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, (2022), vol. 42 br. 4, str. 396-399
Projekat Innovation Fund Denmark [8053-00083B]; William Demant Foundation [20-0242]; H. Lundbeck A/S
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population (Article)
Autori Braten Line Skute  Ingelman-Sundberg Magnus  Jukic Marin M  Molden Espen  Kringen Marianne Kristiansen 
Info CTS-CLINICAL AND TRANSLATIONAL SCIENCE, (2022), vol. 15 br. 9, str. 2135-2145
Projekat South-Eastern Norway Regional Health Authority; European Union`s Horizon 2020 research and innovation program U-PGx [668353]; Swedish Research Council [2021-02732]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients (Article)
Autori Lenk Hasan Cagin  Kloditz Katharina  Johansson Inger  Smith Robert Lovsletten  Jukic Marin M  Molden Espen  Ingelman-Sundberg Magnus 
Info CLINICAL PHARMACOLOGY & THERAPEUTICS, (2022), vol. 111 br. 5, str. 1165-1174
Projekat South--Eastern Norway Regional Health Authority [2020019]; Diakonhjemmet Hospital found for research, innovation, and professional development; Swedish Cancer SocietySwedish Cancer Society [17 0599]; European Research Council (ERC)--Advanced Grant (AdG) project HEPASPHEREuropean Research Council (ERC) [742020]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2021--02732]; European Union's Horizon 2020 research and innovation program [668353/U--PGx]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry (Article)
Autori Molden Espen  Jukic Marin M 
Info FRONTIERS IN PHARMACOLOGY, (2021), vol. 12 br. , str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates (Article)
Autori Jukic Marin M  Smith Robert Lovsletten  Molden Espen  Ingelman-Sundberg Magnus 
Info CLINICAL PHARMACOLOGY & THERAPEUTICS, (2021), vol. 110 br. 3, str. 750-758
Projekat European Commission [2015-02760]; European Union's Horizon 2020 research and innovation program [668353/U-PGx]; Swedish Brain Foundation [FO2019-0260]; South-Eastern Norway Regional Health Authority [2016-09
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram (Article)
Autori Braten Line Skute  Haslemo Tore  Jukic Marin M  Ivanov Maxim  Ingelman-Sundberg Magnus  Molden Espen  Kringen Marianne Kristiansen 
Info CLINICAL PHARMACOLOGY & THERAPEUTICS, (2021), vol. 110 br. 3, str. 786-793
Projekat South-Eastern Norway Regional Health Authority; Diakonhjemmet Hospital found for research, innovation, and professional development; European Commission [668353]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
  • 1
  • 2
Ispis zapisa u formatu:TXT | BibTeX